Thermo Fisher Scientific announces opening of Molecular Biology Center of Excellence in Lithuania

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the official opening of its Molecular Biology Center of Excellence in Vilnius, Lithuania. The new facility will provide molecular, protein and cellular biology products to better serve growing demand from life sciences customers throughout Eastern Europe, and create new opportunities globally. Since acquiring Vilnius-based Fermentas International Inc. in 2010, Thermo Fisher has continued to invest in the region to capitalize on its base of world-class educational institutions and scientific research talent.    

The Vilnius site will showcase world-class capabilities for developing and manufacturing products used in a range of life sciences applications. For example, it provides innovative technologies for PCR-based (polymerase chain reaction) testing, nucleic acid sample preparation protein purification and antibodies for ELISA (enzyme-linked immunosorbent assay) testing.

"Our expanded R&D and manufacturing presence in Vilnius strengthens our ability to serve the growing biotechnology community in Eastern Europe, particularly our research customers who rely on innovations in molecular biology to accelerate developments in diagnosing and treating disease," said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. "We now have a solid foundation from which we can continue to increase our depth of capabilities for high-growth life sciences markets in the region, from PCR-based products to our broader biosciences portfolio."

The 156,000-square-foot Molecular Biology Center of Excellence is currently home to more than 400 research, laboratory and manufacturing personnel, with room for expansion. In addition to its geographically central location, Lithuania is known for its well-established commitment to innovation, highly skilled life sciences workforce and favorable economic environment.

As part of Thermo Fisher's investment in developing the scientific workforce in Lithuania, the company has collaborated with the University of Vilnius to construct a mobile biology laboratory for high school students that provides hands-on experience with molecular biology and DNA experimentation. Thermo Fisher also supports science education in Lithuania through a series of initiatives, including internships and scholarships that provide students with practical experience and financial support.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thermo Fisher Scientific Inc.. (2019, June 20). Thermo Fisher Scientific announces opening of Molecular Biology Center of Excellence in Lithuania. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20120920/Thermo-Fisher-Scientific-announces-opening-of-Molecular-Biology-Center-of-Excellence-in-Lithuania.aspx.

  • MLA

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific announces opening of Molecular Biology Center of Excellence in Lithuania". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20120920/Thermo-Fisher-Scientific-announces-opening-of-Molecular-Biology-Center-of-Excellence-in-Lithuania.aspx>.

  • Chicago

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific announces opening of Molecular Biology Center of Excellence in Lithuania". News-Medical. https://www.news-medical.net/news/20120920/Thermo-Fisher-Scientific-announces-opening-of-Molecular-Biology-Center-of-Excellence-in-Lithuania.aspx. (accessed November 21, 2024).

  • Harvard

    Thermo Fisher Scientific Inc.. 2019. Thermo Fisher Scientific announces opening of Molecular Biology Center of Excellence in Lithuania. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20120920/Thermo-Fisher-Scientific-announces-opening-of-Molecular-Biology-Center-of-Excellence-in-Lithuania.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Thermo Fisher Scientific and Symphogen extend collaboration to boost drug discovery and development